HealthCare Global Enterprises Limited (NSE:HCG)
India
· Delayed Price · Currency is INR 543.50
-5.50 (-1.00%)
Jun 3, 2025, 3:29 PM IST
NSE:HCG Revenue
In the fiscal year ending March 31, 2025, HealthCare Global Enterprises had annual revenue of 22.23B INR with 16.25% growth. HealthCare Global Enterprises had revenue of 5.85B in the quarter ending March 31, 2025, with 18.30% growth.
Revenue
22.23B
Revenue Growth
+16.25%
P/S Ratio
3.44
Revenue / Employee
3.61M
Employees
6,150
Market Cap
76.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 22.23B | 3.11B | 16.25% |
| Mar 31, 2024 | 19.12B | 2.18B | 12.85% |
| Mar 31, 2023 | 16.94B | 2.97B | 21.22% |
| Mar 31, 2022 | 13.98B | 3.84B | 37.93% |
| Mar 31, 2021 | 10.13B | -822.03M | -7.50% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Mankind Pharma | 122.07B |
| Apollo Hospitals Enterprise | 219.94B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |
HealthCare Global Enterprises News
- 6 weeks ago - HCG Aastha Cancer Centre expands operations in Ahmedabad with state’s largest private oncology facility - Business Upturn
- 3 months ago - Q3 2025 Healthcare Global Enterprises Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - KKR & Co Inc (KKR) Acquires Majority Stake in Healthcare Global Enterprises - GuruFocus
- 3 months ago - Healthcare Global stock jump 3.2% after KKR announces 54% stake acquisition for $400 million - Business Upturn
- 3 months ago - KKR to buy 51% in oncology hospital HealthCare Global - The Times of India
- 3 months ago - KKR acquires 54% stake in in Healthcare Global Enterprises for Rs 3,468 crore - Business Upturn
- 7 months ago - HealthCare Global Enterprises Ltd (NSE:HCG) Q2 FY25 Earnings Call Highlights: Robust Revenue ... - GuruFocus
- 7 months ago - Q2 2025 Healthcare Global Enterprises Ltd Earnings Call Transcript - GuruFocus